Compassionate Use" and the Law on Unapproved COVID-19 Drugs
Compassionate Use and other Managed Access Concepts - GMP Journal
Compassionate use - EURORDIS
Compassionate use of orphan drugs | Orphanet Journal of Rare Diseases | Full Text
A case for compassionate use: When unapproved drugs are the only hope
Off-label and Compassionate use of Medications for COVID-19 Treatment
Manufacturer's Compassionate Use Policies: Companies with Posted Policies More Than Doubled Since September 2016
Regulatory Explainer: FDA's Expanded Access (Compassionate Use) Program | RAPS
A case for compassionate use: When unapproved drugs are the only hope
Compassionate use of drugs and medical devices in the United States, the European Union and Japan - ScienceDirect
Compassionate use - EURORDIS
Compassionate Use and other Managed Access Concepts - GMP Journal
Legal basis, terminologies, and regulatory evidence for compassionate... | Download Scientific Diagram
Proportion of Gaucher Patients per country receiving their treatment on... | Download Scientific Diagram
Compassionate Use Policy - BioMarin
Compassionate use in Europe
European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands Subject: IV Zanamivir Procedure No. EMA/H
What is a Compassionate Use Program? - WEP Clinical
Compassionate use: Providing access to much needed treatments | Novartis
PDF) Compassionate use programs in Italy: Ethical guidelines
PharmaBoardroom - Evolving Compassionate Use and Named Patient Programs Across Asia Pacific
Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center | PLOS ONE
Ordinance on Medicinal Products for Compassionate Use
